ConductScience.org, home

Paper39199152

Altered Mitochondrial Function in MASLD: Key Features and Promising Therapeutic Approaches.

Radosavljevic T and 6 others. Antioxidants (Basel), 2024. Cited by 67 papers, by iCite.

Cite this record

ConductScience Library. Altered Mitochondrial Function in MASLD: Key Features and Promising Therapeutic Approaches. Papers, record 39199152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39199152

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Altered Mitochondrial Function in MASLD: Key Features and Promising Therapeutic Approaches.
PubMed
Journal
Antioxidants (Basel)
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
67
iCite
Relative citation ratio, by iCite
11.02, provisional
iCite
Revised in PubMed
2024-09-01
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Radosavljevic TTatjanahttps://orcid.org/0000-0002-1701-3313
2Brankovic MMilica
3Samardzic JJankohttps://orcid.org/0000-0002-8464-4924
4Djuretić JJasminahttps://orcid.org/0000-0002-8457-4962
5Vukicevic DDusan
6Vucevic DDanijela
7Jakovljevic VVladimir

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
451-03-47/2023-01/200111Faculty of Medical Sciences, University of Kragujevac (JP 27/20)PubMed
451-03-66/2024-03/200110; 451-03-65/2024-03/ 200161; 451-03-66/2024-03/ 200161.the Ministry of Science, Technical Development, and Innovation of the Republic of SerbiaPubMed

Source PubMed

Download CSV of grants

References146

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124524207Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review.Nutr J2014https://conductscience.org/library/papers/24524207PubMed
220075336Peroxisome proliferator-activated receptor {delta} is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart.Circ Res2010https://conductscience.org/library/papers/20075336PubMed
331776781Thiazolidinediones: the Forgotten Diabetes Medications.Curr Diab Rep2019https://conductscience.org/library/papers/31776781PubMed
435582982The effect of pharmacological treatment and lifestyle modification in patients with nonalcoholic fatty liver disease: An umbrella review of meta-analyses of randomized controlled trials.Obes Rev2022https://conductscience.org/library/papers/35582982PubMed
531781334Recent Insights into the Mitochondrial Role in Autophagy and Its Regulation by Oxidative Stress.Oxid Med Cell Longev2019https://conductscience.org/library/papers/31781334PubMed
638337575From Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Steatotic Liver Disease: Out with the Old, in with the New.J Clin Med2024https://conductscience.org/library/papers/38337575PubMed
737284220Exercise intervention improves mitochondrial quality in non-alcoholic fatty liver disease zebrafish.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/37284220PubMed
830689995Betaine modulates oxidative stress, inflammation, apoptosis, autophagy, and Akt/mTOR signaling in methionine-choline deficiency-induced fatty liver disease.Eur J Pharmacol2019https://conductscience.org/library/papers/30689995PubMed
938286821Obesity causes mitochondrial fragmentation and dysfunction in white adipocytes due to RalA activation.Nat Metab2024https://conductscience.org/library/papers/38286821PubMed
1034560555Effects of SGLT2 Inhibitors on Ion Homeostasis and Oxidative Stress associated Mechanisms in Heart Failure.Biomed Pharmacother2021https://conductscience.org/library/papers/34560555PubMed
1137179826Mitochondria: It is all about energy.Front Physiol2023https://conductscience.org/library/papers/37179826PubMed
1219084501TZDs reduce mitochondrial ROS production and enhance mitochondrial biogenesis.Biochem Biophys Res Commun2009https://conductscience.org/library/papers/19084501PubMed
1338378752Selpercatinib combination with the mitochondria-targeted antioxidant MitoQ effectively suppresses RET-mutant thyroid cancer.NPJ Precis Oncol2024https://conductscience.org/library/papers/38378752PubMed
1435052595Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease.Antioxidants (Basel)2021https://conductscience.org/library/papers/35052595PubMed
1536601051Avocado oil alleviates non-alcoholic fatty liver disease by improving mitochondrial function, oxidative stress and inflammation in rats fed a high fat-High fructose diet.Front Pharmacol2022https://conductscience.org/library/papers/36601051PubMed
1629634314Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis.Am J Physiol Endocrinol Metab2018https://conductscience.org/library/papers/29634314PubMed
1733332766Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease.Immun Inflamm Dis2021https://conductscience.org/library/papers/33332766PubMed
1831051106Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease.Cell2019https://conductscience.org/library/papers/31051106PubMed
1935126806Empagliflozin Enhances Autophagy, Mitochondrial Biogenesis, and Antioxidant Defense and Ameliorates Renal Ischemia/Reperfusion in Nondiabetic Rats.Oxid Med Cell Longev2022https://conductscience.org/library/papers/35126806PubMed
2035310936Prevention and regression of megamitochondria and steatosis by blocking mitochondrial fusion in the liver.iScience2022https://conductscience.org/library/papers/35310936PubMed

See all 146 referencesDownload CSV of references

Cited by66

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.

PMIDTitleJournalYearIn PapersSource
42939612Glycine Insufficiency as a Metabolic Vulnerability in MASLD: Implications for Precision Nutrition.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42939612PubMed
42871997
Hepatic Overexpression of a Novel Soluble Endogenous Transforming Growth Factor β Type II Receptor-Immunoglobulin G1 Fc Fusion Protein (TβRII-SE/Fc) Attenuates Early Stage Metabolic Dysfunction-Associated Steatotic Liver Disease in Rats.
ACS Pharmacol Transl Sci2026https://conductscience.org/library/papers/42871997PubMed
42825017Ferroptosis in metabolic dysfunction-associated steatotic liver disease.Front Immunol2026https://conductscience.org/library/papers/42825017PubMed
42792248Betaine in Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanisms of Action and Therapeutic Potential.Antioxidants (Basel)2026https://conductscience.org/library/papers/42792248PubMed
42783783Ketogenesis as a Metabolic Checkpoint in MASLD: Implications for Disease Progression and Therapy.Metabolites2026https://conductscience.org/library/papers/42783783PubMed
42778566Metabolic dysfunction-associated steatotic liver disease-a review of the cardiometabolic perspectives and treatments in children.Int J Obes (Lond)2026https://conductscience.org/library/papers/42778566PubMed
42764349Six-compound cocktail for maturation of human pluripotent stem cell-derived liver spheroids for toxicity prediction.Nat Commun2026https://conductscience.org/library/papers/42764349PubMed
42737629Mitochondrial Distress Signals at the Heart-Liver Interface: Molecular Links Between MASLD and Heart Failure.Int J Mol Sci2026https://conductscience.org/library/papers/42737629PubMed
42703413A Shared EGR1-IL-32-Macrophage Polarisation Signature in Rheumatoid Arthritis and Metabolic Dysfunction-Associated Steatotic Liver Disease.J Inflamm Res2026https://conductscience.org/library/papers/42703413PubMed
42660368Mitochondrial antioxidant therapy fails to improve obese asthma outcomes.Respir Med2026https://conductscience.org/library/papers/42660368PubMed
42654005Polyphenol-Rich Euterpe oleracea Mart. Seed Extract Improves High-Fat-Diet-Induced MASLD Through Modulation of Hepatic Mitochondrial Respiration, Biogenesis, and Redox Homeostasis.Molecules2026https://conductscience.org/library/papers/42654005PubMed
42646265Metabolic Rewiring in MASLD: From Disease Mechanisms to Precision Medicine.Metabolites2026https://conductscience.org/library/papers/42646265PubMed
42522599Autophagy in MASLD: A Metabolic and Precision Medicine Perspective.Liver Int2026https://conductscience.org/library/papers/42522599PubMed
42510525Mitochondrial UQCRC2 as a Redox-Regulatory Node in Metabolic and Cardiometabolic Diseases.Antioxidants (Basel)2026https://conductscience.org/library/papers/42510525PubMed
42506440Mitochondrial Dysfunction in Metabolic-Syndrome-Related MASLD/MASH: Metabolic Mechanisms and Therapeutic Perspectives.Metabolites2026https://conductscience.org/library/papers/42506440PubMed
42439696Mechanisms by Which Plant Extracts Ameliorate Bovine Mastitis Through the Regulation of Mitochondrial Function: A Review.Cells2026https://conductscience.org/library/papers/42439696PubMed
42412329Mitophagy in Metabolic Dysfunction-Associated Fatty Liver Disease: Mechanisms, Regulatory Networks, and Therapeutic Perspectives.Inflammation2026https://conductscience.org/library/papers/42412329PubMed
42392672Interplay between MASLD, obesity and type 2 diabetes: epidemiology, shared pathways and clinical implications.BMJ Open Gastroenterol2026https://conductscience.org/library/papers/42392672PubMed
42326688ATR-FTIR Assessment of the Antioxidant and Anti-Inflammatory Effects of (-)-Epicatechin in MASLD.ACS Omega2026https://conductscience.org/library/papers/42326688PubMed
42305303Biomarkers for early identification of metabolic dysfunction-associated steatotic liver disease (MASLD): a narrative review.Arch Med Sci2026https://conductscience.org/library/papers/42305303PubMed

See all 66 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39199152

GET https://conductscience.org/api/papers/v1/39199152/references?page=2